Please use this identifier to cite or link to this item: https://doi.org/10.3389/fimmu.2021.682627
DC FieldValue
dc.titleB7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion
dc.contributor.authorLuu, Khang
dc.contributor.authorSchwarz, Herbert
dc.contributor.authorLundqvist, Andreas
dc.date.accessioned2022-10-26T09:11:25Z
dc.date.available2022-10-26T09:11:25Z
dc.date.issued2021-06-01
dc.identifier.citationLuu, Khang, Schwarz, Herbert, Lundqvist, Andreas (2021-06-01). B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion. Frontiers in Immunology 12 : 682627. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2021.682627
dc.identifier.issn1664-3224
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/233703
dc.description.abstractThe discovery of immune checkpoints highlights the complexity of T cell signalling during an immune response. Upon activation, T cells express several molecules to regulate their function and to prevent overactivation. B7 homolog 7 (B7-H7) is expressed in tumours and associated with a worse prognosis. However, conflicting data regarding its function suggest that it can be both stimulatory and inhibitory. In this study we report that B7-H7 is also expressed on T cells upon cross-linking of CD3 and CD28 and that additional stimulation via CD137 further enhances the expression of B7-H7. B7-H7 is preferentially expressed on exhausted Th1 and Tc1 cells with an impaired secretion of TNF-? and IFN-?. Blockade of B7-H7 with its natural receptor, recombinant CD28H, enhances T cell proliferation and activation. Thus, B7-H7 represents another target for immunotherapy and a biomarker to select for active effector T cells with relevance for adoptive cell transfer therapy. © Copyright © 2021 Luu, Schwarz and Lundqvist.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2021
dc.subjectexhaustion
dc.subjectimmune checkpoint
dc.subjectimmunology
dc.subjectimmunotherapy
dc.subjectT lymphocyte
dc.typeArticle
dc.contributor.departmentPHYSIOLOGY
dc.description.doi10.3389/fimmu.2021.682627
dc.description.sourcetitleFrontiers in Immunology
dc.description.volume12
dc.description.page682627
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fimmu_2021_682627.pdf3.02 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons